# SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients

> **NCT03452293** · — · COMPLETED · sponsor: **EndoCore Lab s.r.l.** · enrollment: 92 (actual)

## Conditions studied

- PAD

## Interventions

- **DEVICE:** Stent Peripheral System

## Key facts

- **NCT ID:** NCT03452293
- **Lead sponsor:** EndoCore Lab s.r.l.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452293, "SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03452293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*